Obstructive Sleep Apnea

Should Mouth Taping Be Used with Oral Appliances to Enhance Efficacy?

A study adds some legitimacy to the viral “sleep hack” of mouth taping—in conjunction with oral appliances—for improved obstructive sleep apnea therapy.

What is Negative Pressure Therapy for Sleep Apnea? Alternative Treatment is Worth a Second Look After Philips CPAP Recall
FDA Grants Breakthrough Designation to Inspire Medical for AHI & BMI Increase
SomnoMed Gets Patient Feedback on Its Pending Smart Oral Appliance Technology
Two New Studies Find No Evidence of Increased Cancer Risk for Philips CPAP Users Vs Users of Non-Recalled Devices
Sommetrics, Which is Developing aerSleep Collar for Sleep Apnea, Gets Chin Cup Patent
Sleep Apnea Detection App SleepCheckRx Receives FDA 510(k) Clearance

Obstructive Sleep Apnea

Digital Solutions Make Neurostimulator Long-Term Patient Management Easier

New launches and upcoming plans from ZOLL Respicardia, Inspire Medical, and LivaNova make patient data more accessible and trackable.

Obstructive Sleep Apnea

How Close Are We to Drug Therapy for Obstructive Sleep Apnea?

No oral pharmacologic treatment to maintain open airways for people with obstructive sleep apnea has been approved by the FDA—yet.

The Evolution of Dental Sleep Medicine with Mitchell Levine

Jun 14, 2022 | Academies & Associations, Obstructive Sleep Apnea, Oral Appliances, Podcasts

Mitchell Levine, DMD, ABDSM, was recently installed as president of AADSM. He discusses how COVID has changed the practice of dental sleep medicine, the role of telehealth, a consensus statement about oral appliance compliance, and more.

FDA Approves Nyxoah Genio 2.1 For Use in DREAM Pivotal Study for Obstructive Sleep Apnea

Jun 9, 2022 | Emerging Technology, FDA, Neurostimulators, Obstructive Sleep Apnea

Genio 2.1’s upgrades are entirely related to the external components of the Genio system, as the implantable stimulator remains unchanged.

Frequent Snorers, Those with Sleep Apnea Less Active During the Day

Jun 8, 2022 | Obstructive Sleep Apnea, Sleep & the Body, Snoring

Researchers examined the relationship between snoring frequency and minutes of sedentary time in three years of data.

Even Two Hours of Nightly CPAP Use Benefits People with Sleep Apnea

May 23, 2022 | CPAP & PAP Devices, Obstructive Sleep Apnea

Benefits begin at 2 hours of nightly CPAP use and increase each hour up to 7 hours per night, according to a study led by ResMed.

Sleep Apnea-Related Deaths Have Been Stable for About a Decade—Except in Black Men, Where Mortality Continues to Rise

May 20, 2022 | Obstructive Sleep Apnea, Race/Ethnicity, Sex

The death of black men from sleep apnea has continued to rise, in contrast to rates that have flattened for white people and Black females.

SleepArchitects Selected for SMILE Health Accelerator

May 17, 2022 | Home Apnea Testing, Obstructive Sleep Apnea, Oral Appliances

Dental sleep startup SleepArchitects, Newport Beach, Calif, was picked as one of the five participating startups out of 100+ applicants.

RespireRx Files Provisional Patent Application for Technology to Improve Sleep Apnea Drug Potential

May 16, 2022 | Emerging Compounds, Obstructive Sleep Apnea

Expansion of dronabinol’s use into OSA and other therapeutic indications will require new, improved formulations, according to RespireRx.

Study: Racial Disparities in Sleep Apnea Mortality

May 13, 2022 | Curated, Demographics, Obstructive Sleep Apnea

A study has found that over the past two decades, more Black men have died from obstructive sleep apnea than white people or Black women.

Inspire Medical Gains Momentum in US & Abroad During Q1

May 10, 2022 | Neurostimulators, Obstructive Sleep Apnea

One key factor driving Inspire’s growth achieved during Q1 was the performance of the company’s Advisor Care Program.

ProSomnus to Be Listed as ‘OSA’ on Nasdaq After Combining with Lakeshore Acquisition

May 10, 2022 | Obstructive Sleep Apnea, Oral Appliances

This transaction is expected to accelerate ProSomnus’ development and commercialization of its oral appliance therapy devices.

Axsome Completes US Acquisition of Sunosi

May 9, 2022 | Narcolepsy, Obstructive Sleep Apnea, Prescription Drugs

‘The Sunosi acquisition marks the transformation of Axsome into a commercial neuroscience company and reflects our commitment to the millions of people living with serious neurologic and psychiatric conditions.’